Fluindione and drug reaction with eosinophilia and systemic symptoms: an unrecognised adverse effect?
Eur J Clin Pharmacol
; 68(1): 101-5, 2012 Jan.
Article
em En
| MEDLINE
| ID: mdl-21792562
ABSTRACT
PURPOSE:
Fluindione is an oral vitamin K antagonist (indanedione derivative) exclusively marketed in France and Luxembourg, known to have immuno-allergic adverse effects such as hepatitis, fever or interstitial nephritis. A few cases of drug reaction with eosinophilia and systemic symptoms (DRESS) have been reported with fluindione. The aim of the present study was to investigate fluindione-induced DRESS cases reported in France and to describe their characteristics.METHODS:
We searched for potential cases of DRESS with fluindione reported in the French pharmacovigilance database since 2000.RESULTS:
Thirty-six cases of DRESS were included and concerned 17 women and 19 men. The mean age was 65 years (median 68 years, range 28-95 years). Kidneys and liver were the most frequent organs involved. Thirty-five cases were serious. In 5 cases, the effect was life-threatening. Most of the patients recovered. Fluindione was the only medicine suspected in 26 cases. Skin patch tests, performed in 10 cases, were positive with fluindione in 9 cases.CONCLUSIONS:
Fluindione is not known to be a frequent cause of DRESS. However, the number of reports found is probably underestimated. The seriousness of DRESS, as all immuno-allergic adverse effects, contraindicates fluindione reintroduction. Coumarinic derivatives are the alternatives in patients who need oral anticoagulant treatment.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Fenindiona
/
Vitamina K
/
Toxidermias
/
Hipersensibilidade a Drogas
/
Eosinofilia
/
Farmacovigilância
/
Anticoagulantes
Tipo de estudo:
Diagnostic_studies
/
Observational_studies
Limite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
País/Região como assunto:
Europa
Idioma:
En
Revista:
Eur J Clin Pharmacol
Ano de publicação:
2012
Tipo de documento:
Article
País de afiliação:
França